Research Article
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study
Table 5
Comparison of changes in HbA1c and BMI for 6 months between the dula continuation group and the switching group. Study 2.
| ||||||||||||||||||||||||
Abbreviations: BMI: body mass index. Data are shown as . |